Carmell Therapeutics Corporation (CTCX)
Largest Insider Buys in Sector
CTCX Stock Price History Chart
CTCX Stock Performance
About Carmell Therapeutics Corporation
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Insider Activity of Carmell Therapeutics Corporation
Over the last 12 months, insiders at Carmell Therapeutics Corporation have bought $94,008 and sold $0 worth of Carmell Therapeutics Corporation stock.
On average, over the past 5 years, insiders at Carmell Therapeutics Corporation have bought $47,575 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Shukla Rajiv (Chairman and CEO) — $61,805. Gregory Kathryn (director) — $21,982. Upton Richard A (director) — $9,964.
The last purchase of 5,000 shares for transaction amount of $2,336 was made by Upton Richard A (director) on 2024‑09‑13.
List of Insider Buy and Sell Transactions, Carmell Therapeutics Corporation
| 2024-09-13 | director | 5,000 0.037% | $0.47 | $2,336 | -29.14% | |||
| 2024-09-10 | Chief Financial Officer | 475 0.0035% | $0.46 | $219 | -28.30% | |||
| 2024-09-06 | director | 1,260 0.0102% | $0.51 | $643 | -27.37% | |||
| 2024-09-06 | director | 1,261 0.0102% | $0.51 | $643 | -27.37% | |||
| 2024-09-06 | director | 1,009 0.0081% | $0.51 | $515 | -27.37% | |||
| 2024-09-06 | director | 1,009 0.0081% | $0.51 | $515 | -27.37% | |||
| 2024-08-30 | director | 109 0.001% | $0.57 | $62 | -45.81% | |||
| 2024-08-30 | director | 109 0.001% | $0.57 | $62 | -45.81% | |||
| 2024-08-30 | director | 87 0.0008% | $0.57 | $50 | -45.81% | |||
| 2024-08-30 | director | 87 0.0008% | $0.57 | $50 | -45.81% | |||
| 2024-08-29 | director | 652 0.0058% | $0.56 | $365 | -36.97% | |||
| 2024-08-29 | director | 652 0.0058% | $0.56 | $365 | -36.97% | |||
| 2024-08-29 | director | 652 0.0058% | $0.56 | $365 | -36.97% | |||
| 2024-08-29 | director | 522 0.0046% | $0.56 | $292 | -36.97% | |||
| 2024-08-29 | director | 522 0.0046% | $0.56 | $292 | -36.97% | |||
| 2024-08-29 | Chief Financial Officer | 1,000 0.009% | $0.57 | $570 | -36.97% | |||
| 2024-08-28 | director | 1,084 0.0096% | $0.56 | $607 | -35.88% | |||
| 2024-08-28 | director | 970 0.0086% | $0.56 | $543 | -35.88% | |||
| 2024-08-28 | director | 749 0.0066% | $0.56 | $419 | -35.88% | |||
| 2024-08-28 | director | 599 0.0053% | $0.56 | $335 | -35.88% |
Insider Historical Profitability
| Shukla Rajiv | Chairman and CEO | 72103 0.3449% | $0.28 | 9 | 0 | |
| Gregory Kathryn | director | 22500 0.1076% | $0.28 | 9 | 0 | |
| Sturgeon Patrick A | director | 18051 0.0863% | $0.28 | 9 | 0 | <0.0001% |
| Upton Richard A | director | 15000 0.0718% | $0.28 | 3 | 0 | |
| Anderson David W | director | 8128 0.0389% | $0.28 | 2 | 0 |